High Tech Pharm Co., Ltd. (KOSDAQ:106190)
14,110
-40 (-0.28%)
At close: Mar 31, 2025, 3:30 PM KST
High Tech Pharm Revenue
In the year 2024, High Tech Pharm had annual revenue of 77.51B KRW with 0.97% growth. High Tech Pharm had revenue of 19.46B in the quarter ending December 31, 2024, a decrease of -17.21%.
Revenue
77.51B
Revenue Growth
+0.97%
P/S Ratio
1.94
Revenue / Employee
1.19B
Employees
65
Market Cap
150.03B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 77.51B | 740.98M | 0.97% |
Dec 31, 2023 | 76.77B | -26.18B | -25.43% |
Dec 31, 2022 | 102.95B | 29.66B | 40.47% |
Dec 31, 2021 | 73.29B | -1.17B | -1.58% |
Dec 31, 2020 | 74.46B | 11.39B | 18.07% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 300.87T |
SK hynix | 66.19T |
LG Energy Solution | 25.62T |
Samsung Biologics | 4,547.32B |
Hyundai Motor Company | 175.23T |
Celltrion | 3,557.30B |
Kia Corporation | 107.45T |
KB Financial Group | 15.01T |